James E. Dahlman
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Molecular Biology top 0.5%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
Papers in
-
- RNA Interference and Gene Delivery 57
- Advanced biosensing and bioanalysis techniques 28
- CRISPR and Genetic Engineering 15
- Lipid Membrane Structure and Behavior 7
-
- MicroRNA in disease regulation 14
- Co-authors
- Róbert Langer (13 shared papers)David Loughrey (22 shared papers)Kalina Paunovska (25 shared papers)Mark W. Tibbitt (1 shared paper)Melissa P. Lokugamage (24 shared papers)Daniel G. Anderson (14 shared papers)Cory D. Sago (15 shared papers)Tyler Jacks (4 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (7 papers)Nano Letters (6 papers)Advanced Materials (5 papers)Nature Biotechnology (4 papers)Nature Communications (4 papers)
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
James E. Dahlman
88 papers receiving 11.1k citations
James E. Dahlman's Hit Papers
Peers
Comparison fields: 5 of 157
- Biomaterials 1.6k
- Molecular Biology 7.7k
- Cancer Research 1.1k
- Business and International Management 148
- Aging 117
Countries citing papers authored by James E. Dahlman
This map shows the geographic impact of James E. Dahlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Dahlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Dahlman more than expected).
Fields of papers citing papers by James E. Dahlman
This network shows the impact of papers produced by James E. Dahlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Dahlman. The network helps show where James E. Dahlman may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Dahlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling Hit paper breakdown → | 2014 | 1574 |
| 2 | Drug delivery systems for RNA therapeutics Hit paper breakdown → | 2022 | 1039 |
| 3 | Treating metastatic cancer with nanotechnology Hit paper breakdown → | 2011 | 1035 |
| 4 | Emerging Frontiers in Drug Delivery Hit paper breakdown → | 2016 | 861 |
| 5 | In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight Hit paper breakdown → | 2014 | 531 |
| 6 | Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs Hit paper breakdown → | 2021 | 422 |
| 7 | Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure Hit paper breakdown → | 2016 | 355 |
| 8 | 2017 | 284 | |
| 9 | 2019 | 271 | |
| 10 | 2018 | 269 | |
| 11 | 2018 | 224 | |
| 12 | 2015 | 217 | |
| 13 | 2014 | 215 | |
| 14 | 2019 | 184 | |
| 15 | 2016 | 182 | |
| 16 | 2011 | 164 | |
| 17 | Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo Hit paper breakdown → | 2022 | 158 |
| 18 | 2021 | 154 | |
| 19 | 2019 | 143 | |
| 20 | 2015 | 139 |
About James E. Dahlman
James E. Dahlman is a scholar working on Molecular Biology, Cancer Research, Immunology and Allergy, Hematology and Immunology, having authored 99 papers that have together received 11.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (57 papers), Advanced biosensing and bioanalysis techniques (28 papers), CRISPR and Genetic Engineering (15 papers), MicroRNA in disease regulation (14 papers), Lipid Membrane Structure and Behavior (7 papers), Virus-based gene therapy research (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Biomaterials (1.6k citations), Molecular Biology (7.7k citations), Cancer Research (1.1k citations), Business and International Management (148 citations) and Aging (117 citations). James E. Dahlman has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Róbert Langer, David Loughrey, Kalina Paunovska, Mark W. Tibbitt, Melissa P. Lokugamage, Daniel G. Anderson, Cory D. Sago, Tyler Jacks, Avi Schroeder and Philip J. Santangelo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nano Letters, Advanced Materials, Nature Biotechnology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.